Biogen Earnings Easily Beat Views, But Biogen Stock Falls – Investor's Business Daily
Business News
- Biogen Earnings Easily Beat Views, But Biogen Stock Falls Investor’s Business Daily
- Biogen Announces 1Q20 Beat, But Aducanumab Update Steals The Show Yahoo Finance
- Roller Coaster Ride Continues For Biogen’s Prospective Alzheimer’s Drug After Employees Battle Coronavirus WBUR
- Biogen’s stock falls 6% though earnings beat expectations MarketWatch
- Biogen aims for Q3 aducanumab filing, quashing expectations of a 2020 nod FierceBiotech
- View Full Coverage on Google News
Source: Business News
